Johnson & Johnson (NYSE: JNJ) is a healthcare giant that sells over-the-counter products, pharmaceuticals, and medical devices. Its diversification makes it a core holding for many investors, including income investors who love its long track …
* J&J - BOARD OF DIRECTORS HAS DECLARED A CASH DIVIDEND FOR Q1 OF 2018 OF $0.84 PER SHARE ON …
U.S. stocks fell Tuesday after weak first-quarter reports from Johnson & Johnson and Goldman Sachs frustrated investors who hope that company earnings are on the rise. Health care companies declined the most. The Standard & Poor's 500 …
When it comes to healthcare, it simply doesn't get any bigger than Johnson & Johnson (NYSE: JNJ). With a market cap of $343 billion, J&J towers more than $140 billion in market value over the second-largest publicly traded healthcare …
Shares of Swiss bio-pharmaceutical company Actelion Ltd. (ALIOF.PK) gained around 17 percent on Friday after drug major Johnson & Johnson (JNJ) confirmed its preliminary talks with Actelion regarding a potential transaction. In its …
ZURICH, Jan 26 (Reuters) - Swiss biotech company Actelion said on Thursday it had agreed to be purchased by Johnson & Johnson in a $30 billion all-cash ... be distributed to Actelion's shareholders as a stock dividend upon closing of the …
Johnson & Johnson took its biggest one-day loss in a year. Investors also looked for safety after the British government called for a surprise early election next month. Bond prices and the pound rose and European stock indexes tumbled. …